3 More Moderna R&D Execs Quietly Step Down
So this year, the Cambridge company has lost the head of its cancer division, its top lawyer, and its chief business officer. Now three more research and development officials have quietly stepped down.
Moderna confirmed the departures of Matthew Stanton, who served as head of chemistry and Barry Ticho, who oversaw development for cardiovascular and metabolic disease.